FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W57141574> ?p ?o ?g. }

• W57141574 endingPage "5046" @default.
• W57141574 startingPage "5046" @default.
• W57141574 abstract "Abstract Background Patients with hyperleukocytic acute myeloid leukemia (AML) have a high mortality rate during induction treatment. This mortality is mainly due to bleeding complications, tumor lysis syndrome and symptoms of hyperleukocitosis. Although there is no clear evidence of benefit, leukapheresis is indicated to reduce the number of leukocytes (WBC) in peripheral blood and prevent or relieve leukostasis symptoms before starting cytotoxic therapy. Objetives Analyze the characteristics of a series of patients with hyperleukocytic AML who started induction treatment and assess the outcome depending on whether leukapheresis was performed or not. Methods All adult patients with hyperleukocytic AML (WBC> 95 x 109 / L) who received induction therapy in the Hospital La Fe between 1979 and 2012 were included. The leukapheresis was indicated according to physician discretion. The characteristics and mortality of both groups, patients who underwent leukapheresis and non-leukapheresis, were compared. Then a “matched-paired analysis” was performed according to ECOG, WBC and coagulopathy in a 2:1 ratio to compare results from two homogeneous cohorts. Results One hundred and forty patients diagnosed with hyperleukocytic AML received induction therapy, 18 of them underwent leukapheresis. Patients who underwent leukapheresis compared with non-leukapheresis showed a median age of 55 years (16-71) vs 58 (14-75) and WBC at diagnosis of 198 ´ 109 / L (101-620) vs 141 (97-375), respectively. The leukapheresis group had a worse ECOG (p = 0.03), more leukocytes (p = .003), more coagulopathy (p = .03), more leukostasis symptoms (p <.001) and more mortality at 7 days (p = .02). From the “matched-paired analysis”, 2 cohorts were obtained, whose characteristics are shown in Table 1. After comparing the group of leukapheresis and non-leukapheresis (n = 36), there were no significant differences between them, including leukocyte count, ECOG, coagulopathy and leukostasis. There were also no significant differences in mortality at 7, 14, 21 and 28 days (p = .60, p = .99, p = .92, p = .99, respectively). Conclusions Patients diagnosed with hyperleukocytic AML who underwent leukapheresis showed more leukocytes, leukostasis and coagulopathy. After analizying two comparable groups, leukapheresis failed to reduce mortality. Disclosures: No relevant conflicts of interest to declare." @default.
• W57141574 created "2016-06-24" @default.
• W57141574 creator A5002126134 @default.
• W57141574 creator A5002349169 @default.
• W57141574 creator A5003682435 @default.
• W57141574 creator A5006535559 @default.
• W57141574 creator A5008004148 @default.
• W57141574 creator A5011914281 @default.
• W57141574 creator A5017341923 @default.
• W57141574 creator A5017621130 @default.
• W57141574 creator A5023129303 @default.
• W57141574 creator A5032130840 @default.
• W57141574 creator A5040307230 @default.
• W57141574 creator A5040488691 @default.
• W57141574 creator A5045788606 @default.
• W57141574 creator A5052934298 @default.
• W57141574 creator A5067166918 @default.
• W57141574 creator A5068008455 @default.
• W57141574 creator A5074938601 @default.
• W57141574 creator A5075385958 @default.
• W57141574 creator A5077942618 @default.
• W57141574 date "2013-11-15" @default.
• W57141574 modified "2023-10-18" @default.
• W57141574 title "Treatment With Leukapheresis In Patients Diagnosed With Hyperleukocytic Acute Myeloid Leukemia" @default.
• W57141574 doi "https://doi.org/10.1182/blood.v122.21.5046.5046" @default.
• W57141574 hasPublicationYear "2013" @default.
• W57141574 type Work @default.
• W57141574 sameAs 57141574 @default.
• W57141574 citedByCount "2" @default.
• W57141574 countsByYear W571415742020 @default.
• W57141574 countsByYear W571415742022 @default.
• W57141574 crossrefType "journal-article" @default.
• W57141574 hasAuthorship W57141574A5002126134 @default.
• W57141574 hasAuthorship W57141574A5002349169 @default.
• W57141574 hasAuthorship W57141574A5003682435 @default.
• W57141574 hasAuthorship W57141574A5006535559 @default.
• W57141574 hasAuthorship W57141574A5008004148 @default.
• W57141574 hasAuthorship W57141574A5011914281 @default.
• W57141574 hasAuthorship W57141574A5017341923 @default.
• W57141574 hasAuthorship W57141574A5017621130 @default.
• W57141574 hasAuthorship W57141574A5023129303 @default.
• W57141574 hasAuthorship W57141574A5032130840 @default.
• W57141574 hasAuthorship W57141574A5040307230 @default.
• W57141574 hasAuthorship W57141574A5040488691 @default.
• W57141574 hasAuthorship W57141574A5045788606 @default.
• W57141574 hasAuthorship W57141574A5052934298 @default.
• W57141574 hasAuthorship W57141574A5067166918 @default.
• W57141574 hasAuthorship W57141574A5068008455 @default.
• W57141574 hasAuthorship W57141574A5074938601 @default.
• W57141574 hasAuthorship W57141574A5075385958 @default.
• W57141574 hasAuthorship W57141574A5077942618 @default.
• W57141574 hasConcept C10205521 @default.
• W57141574 hasConcept C126322002 @default.
• W57141574 hasConcept C141071460 @default.
• W57141574 hasConcept C2777371436 @default.
• W57141574 hasConcept C2777432695 @default.
• W57141574 hasConcept C2778461978 @default.
• W57141574 hasConcept C2778729363 @default.
• W57141574 hasConcept C2778923028 @default.
• W57141574 hasConcept C28328180 @default.
• W57141574 hasConcept C54355233 @default.
• W57141574 hasConcept C71924100 @default.
• W57141574 hasConcept C86803240 @default.
• W57141574 hasConcept C90924648 @default.
• W57141574 hasConceptScore W57141574C10205521 @default.
• W57141574 hasConceptScore W57141574C126322002 @default.
• W57141574 hasConceptScore W57141574C141071460 @default.
• W57141574 hasConceptScore W57141574C2777371436 @default.
• W57141574 hasConceptScore W57141574C2777432695 @default.
• W57141574 hasConceptScore W57141574C2778461978 @default.
• W57141574 hasConceptScore W57141574C2778729363 @default.
• W57141574 hasConceptScore W57141574C2778923028 @default.
• W57141574 hasConceptScore W57141574C28328180 @default.
• W57141574 hasConceptScore W57141574C54355233 @default.
• W57141574 hasConceptScore W57141574C71924100 @default.
• W57141574 hasConceptScore W57141574C86803240 @default.
• W57141574 hasConceptScore W57141574C90924648 @default.
• W57141574 hasIssue "21" @default.
• W57141574 hasLocation W571415741 @default.
• W57141574 hasOpenAccess W57141574 @default.
• W57141574 hasPrimaryLocation W571415741 @default.
• W57141574 hasRelatedWork W2137742605 @default.
• W57141574 hasRelatedWork W2165819952 @default.
• W57141574 hasRelatedWork W24636663 @default.
• W57141574 hasRelatedWork W2551475395 @default.
• W57141574 hasRelatedWork W4230834665 @default.
• W57141574 hasRelatedWork W4382882857 @default.
• W57141574 hasRelatedWork W45497994 @default.
• W57141574 hasRelatedWork W57141574 @default.
• W57141574 hasRelatedWork W71149212 @default.
• W57141574 hasRelatedWork W2502703194 @default.
• W57141574 hasVolume "122" @default.
• W57141574 isParatext "false" @default.
• W57141574 isRetracted "false" @default.
• W57141574 magId "57141574" @default.
• W57141574 workType "article" @default.